LY367385 is a potent, highly selective and competitive mGlu1a receptor antagonist (IC50 = 8.8 μM for blockade of quis-induced phosphoinositide (PI) hydrolysis, compared with >100μM for mGluR5 mediated responses). Water soluble version also available: LY-367385 hydrochloride.
LY367385 impairs induction and late phases of both long term potentiation (LTP) and long term depression (LTD) when applied before high-frequency tetanization (HFT) or low-frequency stimulation (LFS).
LY367385 also displays antidepressant, anticonvulsant and neuroprotective actions.
Solubility & Handling
Storage instructions
Room temperature (desiccate)
Solubility overview
Soluble in 0.1M NaOH (100mM)
Important
This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use.
Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4 carboxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 recept
Bruno V et al (1999) Neuropharmacology 38(2) : 199-207.